ORGENESIS LTD has a total of 36 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARROWHEAD PHARMACEUTICALS INC, BIOTHERAPY INST OF JAPAN and GENETHON.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | China | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Singapore | 3 | |
#7 | Australia | 2 | |
#8 | Canada | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 2 | |
#10 | Mexico | 2 | |
#11 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ferber Sarah | 33 |
#2 | Sarah Ferber | 3 |
#3 | Meivar-Levy Irit | 1 |
#4 | Greenberger Shoshana | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018220623A1 | Compositions and methods for providing cell replacement therapy | |
WO2018207179A1 | Transdifferentiated cell populations and methods of use thereof | |
BR112017014280A2 | transdifferentiation methods and methods of using it | |
KR20160034896A | Cell populations, methods of transdifferention and methods of use thereof |